Quick Answer
PALISADE BIO, INC. reported Cash And Cash Equivalents At Carrying Value of $133.39 million for the year ending 2025.
- PALISADE BIO, INC. showed an increase of +1,258.2% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from PALISADE BIO, INC.'s annual report (Form 10-K), filed with the SEC on March 20, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 18 years of available data (2008 to 2025), PALISADE BIO, INC.'s Cash And Cash Equivalents At Carrying Value has grown by 2,620.3%.
- Historical annual values: Fiscal year 2025: $133.39 million | Fiscal year 2024: $9.82 million | Fiscal year 2023: $12.43 million | Fiscal year 2022: $12.38 million | Fiscal year 2021: $10.50 million | Fiscal year 2020: $713.0 thousand | Fiscal year 2019: $5.11 million | Fiscal year 2018: $5.79 million | Fiscal year 2017: $6.67 million | Fiscal year 2016: $15.19 million | Fiscal year 2015: $4.72 million | Fiscal year 2014: $12.52 million | Fiscal year 2013: $16.85 million | Fiscal year 2012: $7.44 million | Fiscal year 2011: $2.35 million | Fiscal year 2010: $9.26 million | Fiscal year 2009: $2.31 million | Fiscal year 2008: $4.90 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: